Biotech firm CEO pleads guilty to Covid-19 securities fraud scheme ...Middle East

Washington, Dec 9 (IANS) Keith Berman, CEO and director of Decision Diagnostics Corp (DECN), a public medical device company, has pleaded guilty to securities fraud and wire fraud in connection with his scheme to defraud investors by making false and misleading statements about the development of a new, blood-based Covid-19 test, leading to millions of dollars in investor losses. According to court documents, Berman and DECN were in precarious financial condition in the lead up to the Covid-19 pandemic, and Berman wrote in internal emails that he needed a “new story” to “raise millions.” Additionally, Berman had spent hundreds of thousands of dollars of company money on personal expenditures

Hence then, the article about biotech firm ceo pleads guilty to covid 19 securities fraud scheme was published today ( Saturday 09/12/2023 - 11:40 AM ) and is available on News room odisha ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Biotech firm CEO pleads guilty to Covid-19 securities fraud scheme )

Also on site :

• ‘A little touch of luxury, it goes a long way’: Starbucks CEO sees the turn in the turnaround as human touch sings
• What channel is Atletico Madrid v Arsenal Champions League semi-final on? TV coverage, live stream and kick-off time
• Best-Selling Author’s Novel, Ranked ‘Readers’ Favorite Mystery and Thriller,’ Was Built on a Wild Premise